Prestige Consumer Healthcare (PBH) Gross Margin (2010 - 2025)
Prestige Consumer Healthcare (PBH) posted quarterly Gross Margin of 55.52% for Q4 2025, up 5.0% year-over-year from 52.88% in Q4 2024, and little changed quarter-over-quarter from 55.3% in Q3 2025.
Prestige Consumer Healthcare (PBH) Gross Margin (2010 - 2025) Analysis & Trends
Prestige Consumer Healthcare's Gross Margin history runs 16 years deep, the most recent figure standing at 55.52% for Q4 2025.
- In Q4 2025, Gross Margin rose 5.0% year-over-year to 55.52%; the TTM figure through Dec 2025 stood at 56.12% (up 100.0% YoY), while the FY2025 annual figure was 55.76%, up 28.0% from the prior year.
- Gross Margin for Q4 2025 stood at 55.52%, roughly flat from 55.3% in the prior quarter.
- The five-year high for Gross Margin was 59.07% in Q2 2021, with the low at 53.79% in Q1 2023.
- The 5-year median for Gross Margin is 55.71% (2022), against an average of 55.99%.
- The sharpest annual moves came in 2023 and 2025: Gross Margin sank 242 bps in 2023, then jumped 253 bps in 2025.
- Prestige Consumer Healthcare's Gross Margin stood at 56.49% in 2021, then declined by 3 bps to 54.59% in 2022, then increased by 2 bps to 55.86% in 2023, then slipped by 1 bps to 55.47% in 2024, then advanced by 0 bps to 55.52% in 2025.
- Business Quant data shows PBH's Gross Margin at 55.52% in Q4 2025, 55.3% in Q3 2025, and 56.24% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | 51.98% |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | 42.63% |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | 66.66% |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 87.30% |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 38.77% |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 97.58% |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 58.33% |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Prestige Consumer Healthcare | 2.43 Bn | 2.37 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 55.52% |
| Sep 30, 2025 | 55.30% |
| Jun 30, 2025 | 56.24% |
| Mar 31, 2025 | 57.34% |
| Dec 31, 2024 | 55.47% |
| Sep 30, 2024 | 55.46% |
| Jun 30, 2024 | 54.66% |
| Mar 31, 2024 | 54.81% |
| Dec 31, 2023 | 55.86% |
| Sep 30, 2023 | 55.89% |
| Jun 30, 2023 | 55.38% |
| Mar 31, 2023 | 53.79% |
| Dec 31, 2022 | 54.59% |
| Sep 30, 2022 | 55.66% |
| Jun 30, 2022 | 57.79% |
| Mar 31, 2022 | 55.77% |
| Dec 31, 2021 | 56.49% |
| Sep 30, 2021 | 57.10% |
| Jun 30, 2021 | 59.07% |
| Mar 31, 2021 | 57.64% |